Tumori, Every Year in Italy 15 Thousand Candidate Patients with Extensive Genomic Profiling
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.8 Articles
8 Articles
Il Tempo
Rome, 8 Sep. (Adnkronos Salute) - Every year, in Italy, about 15,000 cancer patients are candidates for extensive genomic profiling decided by the Molecular Tumor Board (Mtb). The latter are multidisciplinary teams able to translate molecular information into clinical decision, "offering the most appropriate treatment strategy for patients with advanced disease and without therapeutic alternatives." Indeed, it is demonstrated "that the decisions…
Every year, in Italy, about 15,000 cancer patients are candidates for extensive genomic profiling decided by the Molecular Tumor Board (Mtb). The latter are multidisciplinary teams able to translate molecular information into clinical decision, "offering the most appropriate treatment strategy for patients with advanced disease and without therapeutic alternatives." [...]
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
